Wednesday, March 11, 2020
Pennsylvania Convention Center, Philadelphia, Pennsylvania
At the Pennsylvania Bar Institute (PBI) program “Health Law Institute,” Wilentz Health Law and Corporate Co-Chair Michael F. Schaff will discuss private equity investments in healthcare and Wilentz health law and cannabis attorney Lisa Gora will provide a status update on medicinal marijuana in New Jersey.
During a presentation entitled “How to Manage Physician Expectations of Private Equity Investment in Medical Practices,” Mr. Schaff will consider private equity investments in healthcare from the providers’ perspective, including the Private Equity Business Model, regulatory considerations, and the most common legal pitfalls.
Ms. Gora will present “Update on NJ Cannabis Law,” providing a comprehensive overview of the current state of affairs regarding medicinal cannabis licensing in New Jersey, the role of the Cannabis Regulatory Commission, updates on the New Jersey Hemp Farming Law, and conflict between federal and state laws regarding cannabis.
The annual PBI Health Law Institute provides information on significant developments in health law affecting healthcare professionals from the public and private sectors, including updates on new case law and recent regulatory changes.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.